knowledge -WSS

knowledge

author：focus 2025-10-02 20:48:33 - browse：4142

Photo illustration of Chris Viehbacher -- biotech coverage from STAT — Chris Viehbacher took over as Biogen CEO in November. Suzanne Kreiter/Globe staff; Photo illustration Alex Hogan/STAT

This was supposed to be the new Biogen. When Chris Viehbacher, a respected pharmaceutical executive, took over as CEO in November, Wall Street saw him as a steadying force for the wayward company and a strong personality who would stand up to its quarrelsome board.

Instead, Biogen’s board has saddled Viehbacher with the first crisis of his tenure at the company. Alex Denner, a long-time director, nominated a biotech executive who is also the mother of his child to succeed him on the board, and Biogen chose not to disclose the couple’s relationship to shareholders, an omission that shocked people close to the company and undermined the notion that Biogen was changing for the better.

“It’s just disappointing to see after all the criticism that has been levied at the company over the last few years, there really seems to be no self-awareness going into this recommendation,” said Brian Skorney, a securities analyst at Baird who covers Biogen.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： 'Essentially witchcraft:' A former naturopath takes on the field

WSS

5 takeaways from STAT's examination of Zynex Medical

Trump Jan. 6 attorney John Lauro is ex

Study: Why relieving medical debt did not improve financial outcomes

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

At least 12 people were injured in a blast at a port in northwest Turkey

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

leisure time

knowledge

Wikipedia

Peter Hotez and the public health issue of online harassment

STAT Virtual Event: ASCO Recap, Live!

In age of alternative facts, a scholarly course on calling out crap

5 takeaways from STAT's examination of Zynex Medical

Virginia high school admissions case could be legal follow

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

Medical records are filled with copy

NIH tests clinical research in primary care with $30 million program

Peter Hotez and the public health issue of online harassment

Why workplace violence is so common in health care

explore

Curing rare childhood diseases will falter unless Congress steps up

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

Stephen Quake on the Chan Zuckerberg quest to conquer disease

How faith leaders like me can help address America's obesity epidemic

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

focus

hotspot

focus

focus